Ab Corporate Bond Etf Key Fundamental Indicators
| EYEG Etf | USD 35.87 0.09 0.25% |
As of the 11th of February 2026, AB Corporate owns the Standard Deviation of 0.2193, coefficient of variation of 1157.79, and Market Risk Adjusted Performance of 0.132. AB Corporate Bond technical analysis gives you the methodology to make use of past data patterns to determine a pattern that approximates the direction of the entity's future prices. Please confirm AB Corporate Bond information ratio, and the relationship between the downside deviation and value at risk to decide if AB Corporate Bond is priced fairly, providing market reflects its prevailing price of 35.87 per share.
AB Corporate's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing AB Corporate's valuation are provided below:AB Corporate Bond does not at this moment have any fundamental measures for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Investors evaluate AB Corporate Bond using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating AB Corporate's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause AB Corporate's market price to deviate significantly from intrinsic value.
It's important to distinguish between AB Corporate's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding AB Corporate should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, AB Corporate's market price signifies the transaction level at which participants voluntarily complete trades.
AB Corporate 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AB Corporate's etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AB Corporate.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in AB Corporate on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding AB Corporate Bond or generate 0.0% return on investment in AB Corporate over 90 days. AB Corporate is related to or competes with BondBloxx ETF, Simplify Exchange, TCW ETF, Overlay Shares, Janus Henderson, Janus Henderson, and SPDR SSGA. EyeGate Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing produc... More
AB Corporate Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AB Corporate's etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AB Corporate Bond upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 0.2038 | |||
| Information Ratio | (0.34) | |||
| Maximum Drawdown | 0.9547 | |||
| Value At Risk | (0.31) | |||
| Potential Upside | 0.3669 |
AB Corporate Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for AB Corporate's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AB Corporate's standard deviation. In reality, there are many statistical measures that can use AB Corporate historical prices to predict the future AB Corporate's volatility.| Risk Adjusted Performance | 0.0426 | |||
| Jensen Alpha | 0.0029 | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | (0.36) | |||
| Treynor Ratio | 0.122 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of AB Corporate's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
AB Corporate February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0426 | |||
| Market Risk Adjusted Performance | 0.132 | |||
| Mean Deviation | 0.1781 | |||
| Semi Deviation | 0.14 | |||
| Downside Deviation | 0.2038 | |||
| Coefficient Of Variation | 1157.79 | |||
| Standard Deviation | 0.2193 | |||
| Variance | 0.0481 | |||
| Information Ratio | (0.34) | |||
| Jensen Alpha | 0.0029 | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | (0.36) | |||
| Treynor Ratio | 0.122 | |||
| Maximum Drawdown | 0.9547 | |||
| Value At Risk | (0.31) | |||
| Potential Upside | 0.3669 | |||
| Downside Variance | 0.0415 | |||
| Semi Variance | 0.0196 | |||
| Expected Short fall | (0.21) | |||
| Skewness | (0.06) | |||
| Kurtosis | (0.26) |
AB Corporate Bond Backtested Returns
At this point, AB Corporate is very steady. AB Corporate Bond retains Efficiency (Sharpe Ratio) of 0.0863, which signifies that the etf had a 0.0863 % return per unit of price deviation over the last 3 months. We have found twenty-seven technical indicators for AB Corporate, which you can use to evaluate the volatility of the entity. Please confirm AB Corporate's Standard Deviation of 0.2193, market risk adjusted performance of 0.132, and Coefficient Of Variation of 1157.79 to double-check if the risk estimate we provide is consistent with the expected return of 0.0184%. The entity owns a Beta (Systematic Risk) of 0.0733, which signifies not very significant fluctuations relative to the market. As returns on the market increase, AB Corporate's returns are expected to increase less than the market. However, during the bear market, the loss of holding AB Corporate is expected to be smaller as well.
Auto-correlation | 0.29 |
Poor predictability
AB Corporate Bond has poor predictability. Overlapping area represents the amount of predictability between AB Corporate time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AB Corporate Bond price movement. The serial correlation of 0.29 indicates that nearly 29.0% of current AB Corporate price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.29 | |
| Spearman Rank Test | 0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, AB Corporate Bond has a Price To Earning of -0.85 times. This is much lower than that of the Healthcare family and significantly lower than that of the Corporate Bond category. The price to earning for all United States etfs is notably higher than that of the company.
AB Corporate Bond Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AB Corporate's current stock value. Our valuation model uses many indicators to compare AB Corporate value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AB Corporate competition to find correlations between indicators driving AB Corporate's intrinsic value. More Info.AB Corporate Bond is one of the top ETFs in price to earning as compared to similar ETFs. It also is one of the top ETFs in price to book as compared to similar ETFs . Comparative valuation analysis is a catch-all technique that is used if you cannot value AB Corporate by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.EYEG Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AB Corporate's current stock value. Our valuation model uses many indicators to compare AB Corporate value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AB Corporate competition to find correlations between indicators driving AB Corporate's intrinsic value. More Info.AB Corporate Bond is one of the top ETFs in price to earning as compared to similar ETFs. It also is one of the top ETFs in price to book as compared to similar ETFs . Comparative valuation analysis is a catch-all technique that is used if you cannot value AB Corporate by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.EYEG Fundamentals
| Return On Equity | -103.8 | |||
| Return On Asset | -40.35 | |||
| Current Valuation | 18.1 M | |||
| Shares Outstanding | 7.1 M | |||
| Shares Owned By Insiders | 12.18 % | |||
| Shares Owned By Institutions | 24.20 % | |||
| Number Of Shares Shorted | 54.54 K | |||
| Price To Earning | (0.85) X | |||
| Price To Book | 1.55 X | |||
| Revenue | 12.06 K | |||
| Gross Profit | (3.55 M) | |||
| EBITDA | (9.34 M) | |||
| Net Income | (9.47 M) | |||
| Cash And Equivalents | 3.66 M | |||
| Cash Per Share | 0.29 X | |||
| Total Debt | 308.01 K | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 3.07 X | |||
| Book Value Per Share | 1.26 X | |||
| Cash Flow From Operations | (8.66 M) | |||
| Short Ratio | 0.02 X | |||
| Earnings Per Share | (1.77) X | |||
| Number Of Employees | 14 | |||
| Beta | 0.8 | |||
| Market Capitalization | 13.84 M | |||
| Total Asset | 10.62 M | |||
| Retained Earnings | (108.16 M) | |||
| Working Capital | 102 K | |||
| Current Asset | 6.26 M | |||
| Current Liabilities | 6.16 M | |||
| One Year Return | 6.20 % |
About AB Corporate Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AB Corporate Bond's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AB Corporate using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AB Corporate Bond based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.EyeGate Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing products for treating inflammatory and immune diseases with a focus on the eye and nervous system in the United States. Eyegate Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Waltham, Massachusetts. Eyegate Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Investors evaluate AB Corporate Bond using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating AB Corporate's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause AB Corporate's market price to deviate significantly from intrinsic value.
It's important to distinguish between AB Corporate's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding AB Corporate should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, AB Corporate's market price signifies the transaction level at which participants voluntarily complete trades.